Reversal Caused by n-Butylidenephthalide from the Deficits of Inhibitory Avoidance Performance in Rats

Abstract

The present study was designed to investigate the mechanism of action of n-butylidenephthalide on the deficits of inhibitory avoidance performance induced by drugs in rats with piracetam as a positive control. n-Butylidenephthalide attenuated the scopolamine-induced and mecamylamine-induced acquisition impairment, and also attenuated the acquisition impairment induced by scopolamine plus mecamylamine. Furthermore, scopolamine methylbromide, a peripheral cholinergic muscarinic receptor antagonist, did not block the counteracting effect of n-butylidenephthalide on the scopolamine-induced acquisition impairment. n-Butylidenephthalide attenuated the impairment of inhibitory avoidance performance induced by the central acetylcholinergic neurotoxin AF64A administered intracisternally. From the above results, we suggest that n-butylidenephthalide attenuated the deficits of inhibitory avoidance performance induced by drugs, which are the effects related to activating the central but not the peripheral cholinergic neuronal system via muscarinic and nicotinic receptors.

n-Butylidenephthalide - Angelica sinensis - Apiaceae - inhibitory avoidance task - scopolamine - mecamylamine - AF64A

References

• 1 Watanabe H, Ni J W, Ohta H, Ni X H, Matsumoto K. A kampo prescription, shimotsu-to, improves scopolamine-induced spatial cognitive deficits in rats.  Yakubutsu Seishin Kodo. 1991;  11 215-2
• 2 Ohta H, Ni J W, Watanabe H, Shimizu M. Peony and its major constituent, paeoniflorin, improve radial maze performance impaired by scopolamine in rats.  Pharmacol. Biochem. Behav.. 1993;  45 719-23
• 3 Watanabe H. Candidates for cognitive enhancer extracted from medicinal plants: paeoniflorin and tetramethylpyrazine.  Behav. Brain Res.. 1997;  83 135-41
• 4 Hsieh M T, Lin Y T, Lin Y C, Wu C R. Radix Angelicae sinensis extracts ameliorate scopolamine- and cycloheximide-induced amnesia, but not p-chloramphetamine-induced amnesia in rats.  Am. J. Chin. Med.. 2000;  (in press)
• 5 Ko W C, Chang L D, Wang G Y. Pharmacological effects of butylidenephthalide Phytotherapy Res.  1994;  8 321-6
• 6 Fibiger H C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence.  Trends in Neuroscience. 1991;  14 220-3
• 7 Levin E D, Simon B B. Nicotinic acetylcholine involvement in cognitive function in animals.  Psychopharmacology. 1998;  138 217-30
• 8 Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.  J. Neurochem.. 1986;  46 288-93
• 9 Rush D K. Scopolamine amnesia of passive avoidance: a deficit of information acquisition.  Behav. Neural Biol.. 1988;  50 255-74
• 10 Decker M W, Majchrzak M J. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.  Psychopharmacology. 1992;  107 530-4
• 11 Gouliaev A H, Senning A. Piracetam and other structurally related nootropics.  Brain Res. Rev.. 1994;  19 180-222
• 12 Lin L C, Wang C B, Koh V C, Ko W C. Synthesis, properties and molecular structure of alkylidenephthalides.  Bull. Inst. Chem. Academia. Sinica. 1984;  31 9-15
• 13 Fisher A, Mantione R C, Abraham J D, Hanin I. Long term central cholinergic hypofunction induced in mice by ethylcholine aziridinium (AF64A) in vivo .  J. Pharmacol. Exp. Ther.. 1982;  222 140-5
• 14 Hsieh M T, Wu C R, Hsieh C C. Ameliorating effect of p-hydroxybenzyl alcohol on cycloheximide-induced impairment of passive avoidance response in rats: interactions with compounds acting at 5-HT_1A and 5-HT₂ receptors.  Pharmacol. Biochem. Behav.. 1998;  60 337-43
• 15 Riekkinen P JR, Sirvio J, Aaltonen M, Riekkinen P. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.  Pharmacol. Biochem. Behav.. 1990;  37 405-10
• 16 Peng W H, Hsieh M T, Wu C R. Effect of long-term administration of berberine on scopolamine-induced amnesia in rats.  Jpn. J. Pharmacol.. 1997;  74 261-6
• 17 Yamazaki N, Kato K, Kurihara E, Nagaoka A. Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.  Psychopharmacology. 1991;  103 215-22
• 18 Glick S D, Greenstein S. Differential effects of scopolamine and mecamylamine on passive avoidance behavior.  Life Sci.. 1972;  11 169-79
• 19 Wenk G L. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers.  Psychopharmacology. 1989;  99 431-8
• 20 Rush D K, Streti K. Memory modulation with peripherally acting cholinergic drugs.  Psychopharmacology. 1992;  106 375-82
• 21 Liu M Y, Liu W C. Studies on senile dementia treated with Daqui-Suyi-San.  Chin. Trad. Patent Med.. 1999;  21 428-30
• 22 Huang X X, Hu D, Qu Z W, Zhang J T, Feng Y P. Effect of dl-3-butylphthalide on the striatum extracellular amino acid and dopamine contents in the rat during globe cerebral ischemia.  Acta Pharma. Sinica. 1996;  31 246-9
• 23 Chong Z Z, Feng Y P. Effect of NBP on the release of glutamate and 5-HT from cultured neurons subjected to hypoglycemia/hypoxia.  Chin. Pharm. J.. 1999;  34 589-91
• 24 Matsumoto K, Ojima K, Tezuka Y, Kadota S, Watanabe H. Effects of methylenechloride-soluble fraction of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in group-housed and socially isolated mice.  Life Sci.. 1998;  62 2073-82